doi: 10.1161/hq0202.104100
© 2002 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B
From University Hospital Maastricht (E.T.P.K., M.K., N.C.S., T.W.A.d.B.), Department of Medicine, and Laboratory of Molecular Metabolism and Endocrinology, Cardiovascular Research Institute Maastricht, and University Maastricht (A.P.G.H.), Department of Biophysics, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
Reprint requests to Dr Tjerk W.A. de Bruin, MD, PhD, Department of Medicine and Endocrinology, University Hospital Maastricht, P. Debyelaan 25/PO Box 5800, 6202 AZ Maastricht, Netherlands. E-mail tdb{at}sint.azm.nl
The aim of the present study was to quantify intima-media thickness (IMT) in familial combined hyperlipidemia (FCHL) and to evaluate the relationship of IMT in FCHL-affected subjects with lipids and apolipoproteins, blood pressure values, and surrogate markers of insulin resistance. IMT was measured by ultrasound at the left and right common carotid arteries in 46 FCHL-affected subjects who were free of clinical manifestations of atherosclerosis and in 55 age- and sex-matched healthy control subjects. FCHL-affected subjects had significantly increased IMT compared with healthy control subjects, with a difference of 57 µm (age- and sex-corrected P<0.01). In the FCHL group, significantly positive age- and sex-corrected univariate correlations were observed between IMT and total cholesterol, non-high density lipoprotein cholesterol, and apolipoprotein B. Multivariate regression analyses revealed that age, sex, and apolipoprotein B were significant and independent predictors of IMT, whereas body mass index was of borderline significance. Combined, these factors explained almost 50% of the observed IMT variation (P<0.001). The increased IMT observed in FCHL corresponds with 
7 years of physiological IMT increase in excess of the average IMT in age- and sex-matched control subjects. These novel findings show the important relationship between lipoprotein particles, marked by increased apolipoprotein B concentrations, and an increased IMT in FCHL. The increased IMT in FCHL-affected subjects is in agreement with the known high risk of cardiovascular disease in FCHL.
Key Words: atherosclerosis • body mass index • hypercholesterolemia • insulin resistance
This article has been cited by other articles:
 |
|
 |
|
  M. Juonala, J. S.A. Viikari, T. Ronnemaa, J. Marniemi, A. Jula, B.-M. Loo, and O. T. Raitakari Associations of Dyslipidemias From Childhood to Adulthood With Carotid Intima-Media Thickness, Elasticity, and Brachial Flow-Mediated Dilatation in Adulthood: The Cardiovascular Risk in Young Finns Study Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Chien, H.-C. Hsu, T.-C. Su, M.-F. Chen, Y.-T. Lee, and F. B. Hu Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese J. Lipid Res., November 1, 2007; 48(11): 2499 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M De Michele, A Iannuzzi, A Salvato, P Pauciullo, M Gentile, G Iannuzzo, S Panico, A Pujia, G M Bond, and P Rubba Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia Heart, January 1, 2007; 93(1): 78 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Sniderman Apolipoprotein B Versus Non-High-Density Lipoprotein Cholesterol: And the Winner Is... Circulation, November 29, 2005; 112(22): 3366 - 3367. [Full Text] [PDF]
|
|
|
|
|
|
T. Pischon, C. J. Girman, F. M. Sacks, N. Rifai, M. J. Stampfer, and E. B. Rimm Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men Circulation, November 29, 2005; 112(22): 3375 - 3383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, K. Williams, A. D. Sniderman, R. D'Agostino Jr, and S. M. Haffner Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study Circulation, October 26, 2004; 110(17): 2687 - 2693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Carr and J. D. Brunzell Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2601 - 2607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia J. Lipid Res., November 1, 2003; 44(11): 2100 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J.M. Halkes, H. van Dijk, C. Verseyden, P.P.Th. de Jaegere, H.W.M Plokker, S. Meijssen, D.W. Erkelens, and M. C. Cabezas Gender Differences in Postprandial Ketone Bodies in Normolipidemic Subjects and in Untreated Patients With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1875 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. J. van Greevenbroek, V. M. M-J. Vermeulen, and T. W. A. de Bruin Familial combined hyperlipidemia plasma stimulates protein secretion by HepG2 cells: identification of fibronectin in the differential secretion proteome J. Lipid Res., November 1, 2002; 43(11): 1846 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. H. Eurlings, C. J. H. van der Kallen, J. M. W. Geurts, P. Kouwenberg, W. D. Boeckx, and T. W. A. de Bruin Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyperlipidemia J. Lipid Res., June 1, 2002; 43(6): 930 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Allayee, K. L. Krass, P. Pajukanta, R. M. Cantor, C. J.H. van der Kallen, R. Mar, J. I. Rotter, T. W.A. de Bruin, L. Peltonen, and A. J. Lusis Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia Circ. Res., May 3, 2002; 90(8): 926 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Allayee, K. L. Krass, P. Pajukanta, R. M. Cantor, C. J.H. van der Kallen, R. Mar, J. I. Rotter, T. W.A. de Bruin, L. Peltonen, and A. J. Lusis Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia Circ. Res., May 3, 2002; 90(8): 926 - 931. [Abstract] [Full Text] [PDF]
|
|